TITLE

Ye of little faith

PUB. DATE
September 2007
SOURCE
Marketing Health Services;Fall2007, Vol. 27 Issue 3, p6
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The article focuses on the public's confidence in the U.S. Food and Drug Administration (FDA). The author reports that in 2007, the FDA appears to be rebounding after two years of declining confidence. An online survey, conducted by the Harris Interactive in May 2007 for the Wall Street Journal Online's Health Industry Edition, reveals that 50% of Americans still believe that the FDA is doing a fair or poor job when it comes to ensuring the safety and efficacy of new prescription drugs. The article reveals that the U.S. Senate passed provisions as part of the Food and Drug Administration Revitalization Act that would allow the FDA to issue fines to drug companies if they fail to do follow-up safety studies or use false or misleading advertising.
ACCESSION #
27150121

 

Related Articles

  • Hinchey decries the lack of FDA reform. J. G. D. // Medical Marketing & Media;Aug2006, Vol. 41 Issue 8, p17 

    The article reports that the Congress has refused to act on several bills to reform the Food Drug Administration (FDA), according to Representative Maurice Hinchey in the U.S. It has mentioned that FDA are complex and does not want to make dramatic policy changes without a thorough examination....

  • Newsletter.  // American Family Physician;11/1/2007, Vol. 76 Issue 9, p1265 

    This section offers news briefs on issues related to medical care in the U.S. The U.S. Food and Drug Administration (FDA) will have an increase regulatory oversight under a new medical bill signed by U.S. President George W. Bush. The U.S. Congress has passed a bill that would require insurers...

  • Proposed Rules: DEPARTMENT OF HEALTH AND HUMAN SERVICES.  // Federal Register (National Archives & Records Service, Office of;3/22/2013, Vol. 78 Issue 56, p17611 

    The article offers information on the public notices on the request for comments issued by the U.S. Food and Drug Administration (FDA) regarding the possible changes on Federal drug regulations related to medical gases. It says that written or electronic comments must be submitted on May 21,...

  • FDA, US Hospital and Pharmacy Groups Report Drug Shortages a Growing Problem. Mitka, Mike // JAMA: Journal of the American Medical Association;9/14/2011, Vol. 306 Issue 10, p1069 

    The article reports on the worsening shortage of pharmaceutical drugs in the U.S. as of September 2011 that lead to patients taking less effective drugs or delaying treatment. Legislation has been introduced in Congress, the Preserving Access to Life-Saving Medications Act, which gives the U.S....

  • Drug Efficacy and a Journal's Responsibility. Kimmey, James R. // American Journal of Public Health;Apr1972, Vol. 62 Issue 4, p461 

    The article focuses on the amendments to the Food and Drug Act which require that drugs be proven effective as well as safe before they can be marketed in the U.S. The Food and Drug Administration has been moving slowly to impose these same requirements on drugs already on the market in 1962. It...

  • The FDA Indicts Itself. Faloon, William // Life Extension;Jul2008, Vol. 14 Issue 7, p7 

    The article discusses the issue involving the U.S. Food and Drug Administration (FDA) on medications. It views on the incompetency of the FDA which leads to the suffering and death of millions of Americans. It also presents the report of FDA indicating its mission and the response of the Wall...

  • Orphan Drug Act Turns 25.  // BioWorld Today;1/14/2008, Vol. 19 Issue 9, p6 

    The article announces the 25th anniversary of the Orphan Drug Act, a landmark law that led to an increase in the number of therapies for rare and frequently untreated diseases. In the 25 years since the act was passed into law, more than 1,100 treatments for rare diseases have entered the...

  • FDA mulls hydroquinone rule; derms say concerns unfounded. Jesitus, John // Dermatology Times;Jul2007, Vol. 28 Issue 7, p1 

    The article reports on the new rule proposed by the Food and Drug Administration (FDA) that would classify over-the-counter skin-bleaching products as not as safe and effective, which could pose to an increased risk of cancer in the U.S. The proposal would ban all prescriptions hydroquinone...

  • States act to allow importation of drugs for personal use. Price, Suzanne // Pharmacy Today;Oct2004, Vol. 10 Issue 10, p29 

    The article focuses on the legislations in the U.S. States to allow importation of drugs for personal use. Most recently two states--Illinois and Vermont--have challenged the U.S. Food and Drug Association (FDA) over the issue of drug importation, while the U.S. Congress has not acted on any of...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics